OVID – Ovid Therapeutics Inc.
Ovid Therapeutics Inc.OVID
$2.42Name : Ovid Therapeutics Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $451,669,056.00
EPSttm : -0.21
Ovid Therapeutics Inc.
$2.42
2.54%$0.06
OVID — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
6.03
Margin Of Safety %
Put/Call OI Ratio
0.46
EPS Next Q Diff
0.01
EPS Last/This Y
-0.21
EPS This/Next Y
-0.01
Price
2.41
Target Price
5.5
Analyst Recom
1
Performance Q
13.62
Upside
-228.9%
Beta
0.22
Ticker: OVID
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-05-11 | OVID | 2.8 | 0.71 | 0.27 | 4849 |
| 2026-05-12 | OVID | 2.87 | 0.70 | 0.01 | 4873 |
| 2026-05-13 | OVID | 2.8 | 0.70 | 0.00 | 4898 |
| 2026-05-14 | OVID | 2.8 | 0.69 | 6.76 | 4926 |
| 2026-05-15 | OVID | 2.63 | 0.77 | 0.05 | 5196 |
| 2026-05-18 | OVID | 2.41 | 0.29 | 8.00 | 3476 |
| 2026-05-19 | OVID | 2.38 | 0.31 | 3.20 | 3553 |
| 2026-05-20 | OVID | 2.38 | 0.32 | 0.11 | 3561 |
| 2026-05-21 | OVID | 2.44 | 0.31 | 0.15 | 3583 |
| 2026-05-22 | OVID | 2.46 | 0.31 | 0.33 | 3588 |
| 2026-05-26 | OVID | 2.46 | 0.32 | 0.00 | 3597 |
| 2026-05-27 | OVID | 2.54 | 0.32 | 0.00 | 3596 |
| 2026-05-28 | OVID | 2.65 | 0.32 | 0.00 | 3606 |
| 2026-05-29 | OVID | 2.73 | 0.31 | 0.79 | 3607 |
| 2026-06-02 | OVID | 2.4 | 0.46 | 0.00 | 4029 |
| 2026-06-03 | OVID | 2.4 | 0.46 | 0.00 | 4029 |
| 2026-06-04 | OVID | 2.47 | 0.46 | 0.00 | 4026 |
| 2026-06-05 | OVID | 2.31 | 0.46 | 0.00 | 4026 |
| 2026-06-08 | OVID | 2.36 | 0.46 | 1.50 | 4023 |
| 2026-06-09 | OVID | 2.41 | 0.46 | 0.00 | 4004 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-05-11 | OVID | 2.80 | 24.3 | -191.5 | -0.42 |
| 2026-05-12 | OVID | 2.87 | 24.3 | -198.1 | -0.42 |
| 2026-05-13 | OVID | 2.80 | 24.3 | -165.3 | -0.42 |
| 2026-05-14 | OVID | 2.81 | 24.3 | -30.7 | -0.42 |
| 2026-05-15 | OVID | 2.63 | 24.3 | -23.8 | -0.42 |
| 2026-05-18 | OVID | 2.41 | -46.7 | -21.2 | -0.45 |
| 2026-05-19 | OVID | 2.38 | -46.7 | -28.6 | -0.45 |
| 2026-05-20 | OVID | 2.38 | -75.0 | -29.4 | -0.45 |
| 2026-05-21 | OVID | 2.45 | -75.0 | -33.2 | -0.45 |
| 2026-05-22 | OVID | 2.46 | -75.0 | -31.0 | -0.45 |
| 2026-05-26 | OVID | 2.46 | -75.0 | -30.1 | -0.45 |
| 2026-05-27 | OVID | 2.53 | -75.0 | -33.8 | -0.45 |
| 2026-05-28 | OVID | 2.64 | -75.0 | -35.0 | -0.45 |
| 2026-05-29 | OVID | 2.74 | -75.0 | -34.4 | -0.45 |
| 2026-06-01 | OVID | 2.55 | -73.8 | -22.8 | -0.44 |
| 2026-06-02 | OVID | 2.41 | -73.8 | -24.3 | -0.44 |
| 2026-06-03 | OVID | 2.40 | -73.8 | -30.6 | -0.44 |
| 2026-06-04 | OVID | 2.47 | -73.8 | -33.5 | -0.44 |
| 2026-06-05 | OVID | 2.38 | -73.8 | -26.3 | -0.44 |
| 2026-06-08 | OVID | 2.36 | -73.8 | -28.2 | -0.44 |
| 2026-06-09 | OVID | 2.41 | -73.8 | -33.4 | -0.44 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-05-11 | OVID | -0.10 | 10.09 | 4.53 |
| 2026-05-12 | OVID | -0.10 | 10.09 | 5.55 |
| 2026-05-13 | OVID | -0.10 | 10.09 | 5.55 |
| 2026-05-14 | OVID | -0.10 | 10.09 | 5.55 |
| 2026-05-15 | OVID | -0.10 | 10.09 | 5.15 |
| 2026-05-18 | OVID | -0.10 | 7.05 | 5.06 |
| 2026-05-19 | OVID | -0.11 | 7.05 | 5.06 |
| 2026-05-20 | OVID | -0.11 | 7.05 | 5.06 |
| 2026-05-21 | OVID | -0.11 | 7.05 | 5.06 |
| 2026-05-22 | OVID | -0.11 | 7.05 | 5.06 |
| 2026-05-26 | OVID | -0.11 | 40.87 | 5.09 |
| 2026-05-27 | OVID | -0.11 | 40.87 | 5.09 |
| 2026-05-28 | OVID | -0.11 | 40.87 | 6.03 |
| 2026-05-29 | OVID | -0.11 | 40.87 | 6.03 |
| 2026-06-02 | OVID | -0.11 | 40.45 | 6.03 |
| 2026-06-03 | OVID | -0.11 | 40.45 | 6.03 |
| 2026-06-04 | OVID | -0.11 | 40.45 | 6.03 |
| 2026-06-05 | OVID | -0.11 | 40.45 | 6.03 |
| 2026-06-08 | OVID | -0.11 | 40.45 | 6.03 |
| 2026-06-09 | OVID | -0.11 | 40.45 | 6.03 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.12
Avg. EPS Est. Current Quarter
-0.1
Avg. EPS Est. Next Quarter
-0.11
Insider Transactions
-0.11
Institutional Transactions
40.45
Beta
0.22
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
25
Growth Score
41
Sentiment Score
61
Actual DrawDown %
48
Max Drawdown 5-Year %
-94.3
Target Price
5.5
P/E
Forward P/E
PEG
P/S
63.44
P/B
2.04
P/Free Cash Flow
EPS
-0.24
Average EPS Est. Cur. Y
-0.44
EPS Next Y. (Est.)
-0.45
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-339.31
Relative Volume
0.47
Return on Equity vs Sector %
-39.8
Return on Equity vs Industry %
-23.6
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.44
EBIT Estimation
-33.4
◆
OVID
Healthcare
$2.42
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
44.3
Range 1M
12.8%
Sup Dist
5%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-110%
EPS NY
-10.4%
52W%
75.1%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+127.3% upside
Upside
+127.3%
Quality
25
Ovid Therapeutics Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 23
Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of small molecule medicines for brain disorders including epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and infant drug-resistant epilepsies; and OV4071, a first-in-human oral potassium-chloride cotransporter 2 direct activator which is in Phase 1 clinical trials for the treatment of psychosis associated with parkinson's disease, lewy body dementia, and acute schizophrenia. It has license and collaboration agreements with AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
OVID
Latest News
—
Caricamento notizie per OVID…
stock quote shares OVID – Ovid Therapeutics Inc. Stock Price stock today
news today OVID – Ovid Therapeutics Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch OVID – Ovid Therapeutics Inc. yahoo finance google finance
stock history OVID – Ovid Therapeutics Inc. invest stock market
stock prices OVID premarket after hours
ticker OVID fair value insiders trading